The Valley Desk

NCT01592136 · Expanded access

Expanded Access Program of Ponatinib

Overall registry status Approved for marketing

Conditions Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov